insights_auto
Outlook: 50.0% bullish·3.3% bearish
Go to analysischevron_right
UTHR:NASDAQ
United Therapeutics Corp
$587.88
arrow_downward
-0.56%(-3.29) 1D
$587.88
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 16, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 14 analysts giving stock ratings to UTHR in the past 3 months
Buy
Buy
11
Hold
2
Sell
1
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for UTHR in the last 3 months.
Highest
Current $587.88
$850.00 (+44.59%)
Average
$682.71 (+16.13%)
Lowest
$368.00 (-37.40%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Matthew Caufield H.C. Wainwright | Buy | Initiated | $660.00 | +12.3% | 11/09/2026 |
Roanna Ruiz Leerink Partners | Buy | Reiterated | $725.00 | +23.3% | 11/05/2026 |
Joseph Thome TD Cowen | Buy | Reiterated | $700.00 | +19.1% | 11/05/2026 |
Terence Flynn Morgan Stanley | Hold | Reiterated | $568.00 | -3.4% | 11/05/2026 |
Lisa Walter RBC Capital | Buy | Reiterated | $725.00 | +23.3% | 11/04/2026 |
Julian Harrison BTIG | Buy | Maintained | $768.00 | +30.6% | 11/04/2026 |
Benjamin Burnett Wells Fargo | Buy | Reiterated | $703.00 | +19.6% | 11/05/2026 |
Jason Gerberry Bank of America Securities | Hold | Maintained | $650.00 | +10.6% | 11/04/2026 |
Jessica Fye J.P. Morgan | Buy | Reiterated | $695.00 | +18.2% | 10/28/2026 |
Olivia Brayer Cantor Fitzgerald | Buy | Maintained | $850.00 | +44.6% | 10/26/2026 |
Tiago Fauth Raymond James | Buy | Maintained | $717.00 | +22% | 10/20/2026 |
Andrea Newkirk Goldman Sachs | Sell | Maintained | $368.00 | -37.4% | 10/15/2026 |
Ashwani Verma UBS | Buy | Maintained | $725.00 | +23.3% | 10/13/2026 |
Roger Song Jefferies | Buy | Maintained | $704.00 | +19.8% | 10/01/2026 |
Andrew Fein H.C. Wainwright | Buy | Maintained | $660.00 | +12.3% | 08/06/2026 |
Unknown Analyst J.P. Morgan | Buy | Maintained | $685.00 | +16.5% | 05/20/2026 |
Unknown Analyst Raymond James | Buy | Initiated | $700.00 | +19.1% | 04/09/2026 |
Andreas Argyrides Oppenheimer | Buy | Maintained | $650.00 | +10.6% | 03/12/2026 |
Jasper Hellweg Argus Research | Buy | Reiterated | $560.00 | -4.7% | 03/03/2026 |